Prenatal exposure to thyroid drugs may cause birth defects

10/22/2013 | MedPage Today (free registration)

Infants born to mothers who took hyperthyroidism drugs propylthiouracil and methimazole during early pregnancy were more likely to develop birth defects than those born to women in the general population who didn't take the drugs, according to an analysis of data from Denmark. Prenatal exposure to methimazole was linked to more musculoskeletal defects, and neck and facial problems were linked with propylthiouracil. The study was presented at a meeting of the American Thyroid Association.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN